The association of ecstasy use and academic achievement among adolescents in two U.S. national surveys.
The association of ecstasy (3, 4-methylenedioxymethamphetamine, MDMA) use with low academic achievement was examined in two nationally representative surveys of adolescents. We tested whether associations with low academic achievement were of similar magnitude or of stronger magnitude for ecstasy versus marijuana use (without ecstasy use), alcohol/tobacco use (without other drug use) and non-drug use in adolescence. Data from the adolescents in the 2002-2005 National Survey of Drug Use and Health (NSDUH, n=65,294) and from the 2001-2003 Youth Risk Behavior Survey (YRBS, n=27,592) were analyzed via weighted logistic regression models. Ecstasy, marijuana, and alcohol/tobacco use were associated with moderate and low academic achievement among adolescents in both surveys. Moreover, ecstasy was more strongly associated with low academic achievement and reporting that school gave no grades than alcohol/tobacco in both samples and than marijuana (NSDUH sample only). Prevention programs should inform adolescents that ecstasy use might impair their academic achievement.
Martins
Silvia S
SS
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205-190, United States. smartins@jhsph.edu
Alexandre
Pierre K
PK
D000293:Adolescent; D019969:Amphetamine-Related Disorders / Q000523:psychology*; D001294:Attitude to Health; D002648:Child; D004522:Educational Status; D005260:Female; D006213:Hallucinogens / Q000009:adverse effects*; D006801:Humans; D008297:Male; D002189:Marijuana Abuse / Q000523:psychology*; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*; D012309:Risk-Taking; D012572:School Health Services; D012907:Smoking / Q000523:psychology*; D011795:Surveys and Questionnaires; D014481:United States
D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine
Toxicol Lett. 2000 Mar 15;112-113:147-52
10720724
Addiction. 2000 Apr;95(4):505-20
10829327
J Sch Health. 2007 Mar;77(3):109-15
17302852
Health Econ. 1996 Jan-Feb;5(1):77-92
8653193
Am J Drug Alcohol Abuse. 2002;28(1):15-35
11853131
Addict Behav. 2007 Jul;32(7):1511-8
17174036
J Psychoactive Drugs. 2003 Jul-Sep;35(3):301-9
14621128
Exp Clin Psychopharmacol. 2005 Aug;13(3):244-52
16173888
Health Econ. 2000 Jan;9(1):9-18
10694756
Drug Alcohol Depend. 2003 Oct 24;72(1):33-44
14563541
Addiction. 2006 Apr;101(4):556-69
16548935
JAMA. 2003 Jan 22-29;289(4):482-3
12533129
Addict Behav. 2008 Jul;33(7):919-33
18355973
Drug Alcohol Depend. 2008 Apr 1;94(1-3):63-72
18068314
Addiction. 2000 Nov;95(11):1621-30
11219366
J Psychoactive Drugs. 2002 Apr-Jun;34(2):145-62
12691205
Br J Addict. 1987 Apr;82(4):331-42
3472582
Am J Epidemiol. 1995 Mar 15;141(6):575-80
7900725
Arch Gen Psychiatry. 1996 Jan;53(1):71-80
8540779
Adolescence. 2001 Winter;36(144):795-802
11928883
Psychopharmacology (Berl). 2001 Mar 1;154(2):161-8
11314678
Health Econ. 2006 May;15(5):489-511
16389630
Hum Psychopharmacol. 2003 Oct;18(7):507-17
14533132